Indoco Remedies: Trading Window Closed for Q3 FY26 Results

Indoco Remedies Limited has announced the closure of its trading window for dealing in the company's equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations...

Indoco Remedies Limited has announced the closure of its trading window for dealing in the company's equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Thursday, 01st January, 2026. It will reopen 48 hours after the declaration of the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2025. During this period, designated persons of the company, including their immediate relatives, are advised not to trade in the company's equity shares. The date of the Board Meeting to approve these financial results will be intimated in due course.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Indoco Remedies Limited in the news today?

Indoco Remedies Limited (INDOCO) is in the news due to the announcement is a standard regulatory disclosure regarding the closure of the trading window, which is a routine procedure before financial results are announced. it does not contain any new financial information or strategic developments.

Trading Window DisclosureQuarterly Results
Indoco Remedies LimitedINDOCOhttps://prysm.fi/v2/analyze/INDOCO

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Indoco Remedies: Trading Window Closed for Q3 FY26 Results

December 30, 2025, 01:43 PM

AI Sentiment Analysis

Top Queries to Ask About Indoco Remedies Limited

More Details on This News

Indoco Remedies Limited has announced the closure of its trading window for dealing in the company's equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.

The trading window will be shut from Thursday, 01st January, 2026. It will reopen 48 hours after the declaration of the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2025.

During this period, designated persons of the company, including their immediate relatives, are advised not to trade in the company's equity shares. The date of the Board Meeting to approve these financial results will be intimated in due course.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Indoco Remedies Limited

Discover more trending news on Prysm

View All